Table 2.
Gain | Loss | |||
---|---|---|---|---|
Measurement | M (SD) | Range | M (SD) | Range |
No. of trials | ||||
Baseline | 29.36 (1.64) | 18–30 | 29.32 (1.68) | 19–30 |
Eight weeks | 29.47 (1.51) | 14–30 | 29.43 (1.51) | 20–30 |
Data quality | ||||
SMEij | ||||
Baseline | 1.53 (0.41) | 0.73–3.95 | 1.48 (0.55) | 0.66–8.05 |
Eight weeks | 1.60 (0.46) | 0.74–4.24 | 1.56 (0.47) | 0.73–3.74 |
σij | ||||
Baseline | 8.25 (2.14) | 3.80–16.77 | 7.99 (2.69) | 3.45–36.87 |
Eight weeks | 8.65 (2.35) | 3.91–22.83 | 8.44 (2.52) | 3.99–20.48 |
Group-level internal consistency | ||||
Estimate | 95% CI | Estimate | 95% CI | |
r xx | ||||
Baseline | 0.95 | — | 0.93 | — |
Eight weeks | 0.93 | — | 0.93 | — |
α | ||||
Baseline | 0.94 | (0.93, 0.95) | 0.94 | (0.93, 0.95) |
Eight weeks | 0.93 | (0.92, 0.95) | 0.93 | (0.92, 0.95) |
ϕk | ||||
Baseline | 0.93 | (0.92, 0.94) | 0.93 | (0.92, 0.94) |
Eight weeks | 0.93 | (0.91, 0.94) | 0.93 | (0.91, 0.94) |
ICC | ||||
Baseline | 0.32 | (0.28, 0.36) | 0.30 | (0.27, 0.34) |
Eight weeks | 0.28 | (0.23, 0.32) | 0.27 | (0.23, 0.32) |
Subject-level internal consistency | ||||
M (SD) | Range | M (SD) | Range | |
ϕjk | ||||
Baseline | 0.93 (0.02) | 0.81–0.96 | 0.93 (0.03) | 0.58–0.96 |
Eight weeks | 0.92 (0.03) | 0.77–0.97 | 0.92 (0.03) | 0.79–0.97 |
ICC | ||||
Baseline | 0.33 (0.06) | 0.18–0.49 | 0.32 (0.06) | 0.06–0.46 |
Eight weeks | 0.30 (0.06) | 0.10–0.48 | 0.30 (0.06) | 0.11–0.48 |
Note: All estimates based on N = 276 at baseline and N = 187 at 8 weeks. SMEij = standard measurement error; σij = between-trial standard deviation; rxx = odd–even reliability with Spearman–Brown Prophecy adjustment; α = Cronbach’s alpha; ϕk = group-level dependability; ϕjk = subject-level dependability.